(Q28361651)

2

0 references

A K Taylor

3

0 references

B R Korf

4

0 references

J A Heit

https://scigraph.springernature.com/pub.10.1097/00125817-200103000-00009

5

0 references

language of work or name

English

0 references

publication date

2001

1 reference

0 references

3

0 references

issue

2

0 references

page(s)

139-48

0 references

exact match

0 references

cites work

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

The mechanism of inactivation of human factor V and human factor Va by activated protein C

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Inherited thrombophilia and pregnancy loss.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Heritable coagulopathies in pregnancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Combined oral contraceptives, smoking, and cardiovascular risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

The factor V Leiden mutation may predispose women to severe preeclampsia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Activated protein C resistance and thrombosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

The lupus anticoagulant/antiphospholipid syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Increased frequency of genetic thrombophilia in women with complications of pregnancy.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Factor V Arg306-->Thr (factor V Cambridge) and factor V Arg306-->Gly mutations in venous thrombotic disease.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Factor V Leiden mutation as a risk factor for recurrent pregnancy loss.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Factor V Leiden and other coagulation factor mutations affecting thrombotic risk.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Resistance to activated protein C as a basis for venous thrombosis.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Plasma Homocysteine in Venous Thromboembolism

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

2 June 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden).

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Probability of recurrence of thrombosis in patients with and without factor V Leiden.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3111091

Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis

27 November 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Activated protein C resistance caused by Arg506Gln mutation in factor Va

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Characterization of the molecular defect in factor VR506Q

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Modified APC resistance assay for patients on oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Prevention of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Smoking and use of oral contraceptives: impact on thrombotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Simultaneous polymerase chain reaction restriction fragment length polymorphism identification of the factor V Leiden allele and the prothrombin 20210A mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Non-PCR-dependent detection of the factor V Leiden mutation from genomic DNA using a homogeneous invader microtiter plate assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Prothrombin G20210A mutation in a child with spinal cord infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Plasma homocysteine levels in patients with deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200103000-00009

Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency

21 January 2018

1 reference

12 December 2020

Oral contraceptives and screening for factor V Leiden

1 reference

12 December 2020

Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women

1 reference

12 December 2020

The risk of recurrent venous thromboembolism in patients with and without factor V Leiden

1 reference

12 December 2020

Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis

1 reference

12 December 2020

A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women

1 reference

12 December 2020

A novel mutation of Arg306 of factor V gene in Hong Kong Chinese

1 reference

12 December 2020

Homocysteine and vitamins in cardiovascular disease

1 reference

12 December 2020

Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR

1 reference

12 December 2020

The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C

1 reference

12 December 2020

High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

1 reference

12 December 2020

Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

1 reference

12 December 2020

Management of patients with hereditary defects predisposing to thrombosis including pregnant women

1 reference

12 December 2020